Advertisement

Topics

[Articles] Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial

20:27 EDT 14 Jun 2018 | The Lancet

Belimumab might be a useful adjunct to standard-of-care immunosuppression in renal transplantation, with no major increased risk of infection and potential beneficial effects on humoral alloimmunity.

Original Article: [Articles] Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial

NEXT ARTICLE

More From BioPortfolio on "[Articles] Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...